A - Agilent Technologies, Inc.
| Previous Close | 71.13 |
| Open | 71.43 |
| Bid | 60.25 x 900 |
| Ask | 0.00 x 2200 |
| Day's Range | 70.56 - 71.46 |
| 52 Week Range | 60.42 - 75.00 |
| Volume | 3,119,673 |
| Avg. Volume | 2,086,050 |
| Market Cap | 22.543B |
| Beta | 1.36 |
| PE Ratio (TTM) | 77.46 |
| EPS (TTM) | 0.91 |
| Earnings Date | Nov 19, 2018 - Nov 23, 2018 |
| Forward Dividend & Yield | 0.60 (0.87%) |
| Ex-Dividend Date | 2018-07-02 |
| 1y Target Est | 78.07 |
- Reuters•7 hours ago
Factbox - U.S. companies react on impact of Trump trade tariffs
The U.S. administration will begin to levy new tariffs of 10 percent on about $200 billion of Chinese products on Sept. 24, with the tariffs to go up to 25 percent by the end of 2018. The following are comments made by U.S. companies after the Trump administration said on July 10 https://reut.rs/2m6Yu0r that it would slap tariffs on $200 billion of Chinese imports. ** Walmart Inc (WMT.N) warned that it may raise prices of products if the Trump administration imposes a tariff on Chinese imports.
- Zacks•22 hours ago
TER vs. A: Which Stock Should Value Investors Buy Now?
TER vs. A: Which Stock Is the Better Value Option?
Markit•23 hours agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Business Wire•3 days ago
Agilent Technologies Announces Cash Dividend of 14.9 Cents per Share
Agilent Technologies Inc. (NYSE:A) today announced that a quarterly dividend of 14.9 cents per share of common stock will be paid on October 24, 2018, to all shareholders of record as of the close of business on October 2, 2018. Agilent Technologies Inc. (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.
- Zacks•4 days ago
Electronics Testing Equipment Outlook: Solid Demand Ahead
Electronics Testing Equipment Outlook: Solid Demand Ahead
- Business Wire•4 days ago
Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents
Agilent Technologies Inc. filed a new complaint against Twist Bioscience Corp. and Emily Leproust. The proposed Second Amended Complaint adds two additional defendants and adds new facts that were recently discovered regarding the defendants’ wide-ranging theft of Agilent’s proprietary oligonucleotide synthesis technology.
Markit•4 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting A. A credit default swap spreads are within the middle of their range for the last three years.
- Benzinga•5 days ago
A Life Science Tools And Diagnostics Pair Trade: Goldman Recommends Buying Agilent, Moving to Sidelines On Thermo Fisher
Analyst Patrick Donnelly maintained a Buy rating on Agilent Technologies Inc (NYSE: A) and increased the price target from $77 to $82. The analyst added Agilent to Goldman's Americas Conviction List and also named it as a top pick. At the same time, Donnelly downgraded shares of Thermo Fisher Scientific Inc. (NYSE: TMO) from Buy to Neutral and maintained a $250 price target.
- MarketWatch•5 days ago
Thermo Fisher shares fall as Goldman downgrades to neutral; Agilent added to conviction list
Thermo Fisher Scientific Inc. shares slid 1.9% Monday, after Goldman Sachs downgraded the stock to neutral from buy on valuation grounds. Goldman removed Thermo Fisher from its Americas Conviction List and added Agilent Technologies Inc. , which it now deems its top pick in life science tools and diagnostics. Agilent shares rose 0.5%. "We see this as an opportunistic time to make the switch to A given the set-up and valuation, with Agilent providing a rare Tools opportunity to own an accelerating growth story at a reasonable valuation with untapped capital allocation upside that could potentially be unlocked by the new CFO in our view," analysts wrote in a note. On Thermo, "we believe our thesis for deal-driven accelerating growth and margin expansion has been more appropriately reflected in valuation while the company faces a difficult set of comps starting in 4Q18," they wrote. Goldman is still positive on the fundamentals of both companies, and expects beats and raises in the next few quarter. Analysts raised their stock price target for Agilent to $82 from $77, but kept its stock price target for Thermo at $250. Thermo shares have gained 29% since they were added to Goldman's Conviction List. Shares have gained 25% in 2018, while Agilent has gained 3.3%. The S&P 500 has gained 8%.
- Simply Wall St.•9 days ago
Who Are The Major Shareholders In Agilent Technologies Inc (NYSE:A)?
A look at the shareholders of Agilent Technologies Inc (NYSE:A) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and we usually see insidersRead More...
- Zacks•9 days ago
Why Is Agilent (A) Up 4.9% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Markit•9 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- American City Business Journals•9 days ago
Health Care Heroes award winner: Dr. Allison Freeman, Allegheny Health Network
Dr. Allison Freeman is a winner of a 2018 Health Care Hero award in the health care provider - individual category.
- Market Realist•10 days ago
How Thermo Fisher Scientific’s Valuation Looks in September
Thermo Fisher Scientific (TMO) provides equipment, software, analytical instruments, reagents, consumables, and services. Thermo Fisher reported non-GAAP EPS of $2.75 on revenues of ~$6.1 billion, a 21.8% increase as compared to ~$5.0 billion during the second quarter of 2017. The below chart compares revenues and EPS for Thermo Fisher Scientific since the first quarter of 2017.
Markit•11 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting A. A credit default swap spreads are within the middle of their range for the last three years.
- Reuters•12 days ago
Factbox: U.S. tech firms bemoan impact of Trump trade tariffs
The following are comments made by U.S. tech companies since Trump's announcement. ** Apple Inc said a "wide range" of its products including the Apple Watch would be affected by proposed U.S. tariffs on Chinese goods but gave no sign of an impact on its iPhone. Apple said its MacMini, a low-priced computer that comes without a keyboard or mouse, would be affected.
- Business Wire•15 days ago
Agilent Early Career Professor Award Presented to Christoph Thaiss at University of Pennsylvania
Agilent Technologies Inc. (NYSE:A) today announced that the winner of the 2018 Agilent Early Career Professor Award is Christoph Thaiss, Ph.D., assistant professor of microbiology in the Perelman School of Medicine at the University of Pennsylvania. Dr. Thaiss’s research focuses on the microbiome and how it mediates the response of its host to environmental cues, which strongly influences the organism’s health and disease states. “We are very happy to support Dr. Thaiss and his transformative microbiome research," said Jack Wenstrand, director of University Relations and External Research at Agilent.
- Business Wire•16 days ago
Agilent Recognized as Aon Best Employer in Malaysia for 2018
Agilent Technologies Inc. (NYSE:A) today announced that it has been recognized as one of Aon’s Best Employers in Malaysia for 2018. Agilent received the honor from Aon at an award ceremony this week in Kuala Lumpur, Malaysia. Aon is a leading global professional services firm that provides a broad range of risk, retirement, and health solutions through its flagship program Aon Best Employers.
- Zacks•16 days ago
TER vs. A: Which Stock Should Value Investors Buy Now?
TER vs. A: Which Stock Is the Better Value Option?
- Market Realist•18 days ago
Trump’s Tariffs: More Countries Investigate China
President Trump has imposed tariffs on billions of dollars of Chinese goods. More tariffs have been proposed. Along with these China-specific tariffs, there are also the Section 232 tariffs on US steel and aluminum imports, which cover several other countries.
- Market Realist•29 days ago
How Is Roche’s Diagnostics Segments Positioned in August?
In Roche’s Diagnostics division, the Centralized Point of Care Solutions segment reported first-half revenues of 3.76 billion Swiss francs, reflecting ~6.0% YoY growth at CER (constant exchange rates). In the second quarter, Roche’s (RHHBY) Centralized and Point of Care Solutions reported revenues of 2.0 billion Swiss francs, which reflected ~9.0% YoY growth at CER.
Zacks•last month5 Tech Stocks Momentum Investors Should Buy Right Now
Technology has been one of the most lucrative sectors for investors, year to date.
- American City Business Journals•last month
Meet Group adds new one-on-one video chat feature, ups revenue
The dating and chat app upped annual video revenue run rate for the second time this year, from $29 million to $35 million and now $42 million.
- Business Wire•last month
Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma
PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA®
- Thomson Reuters StreetEvents•last month
Edited Transcript of A earnings conference call or presentation 14-Aug-18 8:30pm GMT
Q3 2018 Agilent Technologies Inc Earnings Call
